| 1 | 438618-32-7 | Glucagon Receptor Antagonist I | Glucagon Receptor Antagonist I | C20H30N2OS
| | |
| 2 | 444155-80-0 | N-(5-methyl-1,3-benzothiazol-2-yl)dodecanamide | N-(5-methyl-1,3-benzothiazol-2-yl)dodecanamide | C20H30N2OS
| | |
| 3 | 445251-73-0 | N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothien-2-yl)decanamide | N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothien-2-yl)decanamide | C20H30N2OS
| | |
| 4 | | N-BENZYL-N-(1-[(CYCLOHEXYLAMINO)CARBOTHIOYL]-2-METHYLPROPYL)ACETAMIDE | N-BENZYL-N-(1-[(CYCLOHEXYLAMINO)CARBOTHIOYL]-2-METHYLPROPYL)ACETAMIDE | C20H30N2OS
| | |
| 5 | | N-(2,2-Dimethyltetrahydro-2H-thiopyran-4-yl)-N-phenyl-1-piperidineacetamide | N-(2,2-Dimethyltetrahydro-2H-thiopyran-4-yl)-N-phenyl-1-piperidineacetamide | C20H30N2OS
| | |
| 6 | | 2-{[4-(tert-butyl)phenyl]thio}-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetamide | 2-{[4-(tert-butyl)phenyl]thio}-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetamide | C20H30N2OS
| | |